Healthcare & Life Sciences
Rege Nephro
Rege Nephro is a Healthcare & Life Sciences startup based in Japan, most recent round Series B, 1 tracked investor.
activeseries-b
series-b
Stage
2017
Founded
1
Investors
About Rege Nephro
Rege Nephro is a startup founded in 2017 based in Japan. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Rege Nephro develops therapeutic drugs for renal diseases using iPS cell technology, focusing on cell therapy and small molecule treatments for conditions like chronic kidney disease (CKD) and autosomal dominant polycystic kidney disease (ADPKD).
Explore Rege Nephro's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.